HR 2871 · 115th Congress 2017–2019, ended

Preserving Patient Access to Compounded Medications Act of 2017

Latest action · Jun 16, 2017 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJun 12, 2017
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Preserving Patient Access to Compounded Medications Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to expand the circumstances under which a drug may be compounded (manufactured at small scale) to allow pharmacists and physicians to compound drugs for administration to patients in an office or clinical setting, in accordance with state law. (Drugs that are compounded do not need to meet certain federal requirements regarding manufacturing, labeling, or approval.)

Dietary supplements may be used in the compounding of a drug.

The bill exempts from interstate distribution limits the dispensing of a compounded drug from the facility where it is compounded to a patient or health facility.

The scope of Food and Drug Administration (FDA) inspections of compounding pharmacies is limited to pertinent equipment, materials, containers, and labeling, which is the same scope as inspections of pharmacies. (Currently, the scope of inspections of compounding pharmacies is the same scope as inspections of drug manufacturers.)

The bill eliminates the requirement for compounding pharmacies to register with the FDA as drug manufacturers.

Cosponsors 62

Members who signed on, in the order they did. Signatures ran from Jun 12, 2017 to Jul 26, 2018; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-TXHenry CuellarOriginalJun 12, 2017
R-NYChris CollinsJun 15, 2017
R-TXTed PoeJun 15, 2017
R-GAEarl L. "Buddy" CarterJun 21, 2017
R-NJFrank A. LoBiondoJun 21, 2017
R-TXPete SessionsJun 21, 2017
R-TNDavid P. RoeJun 22, 2017
R-TXMac ThornberryJun 22, 2017
R-AZAndy BiggsJun 27, 2017
R-WACathy McMorris RodgersJun 29, 2017
R-MSGregg HarperJul 12, 2017
R-IADavid YoungJul 13, 2017
R-AZPaul A. GosarJul 18, 2017
D-MNCollin C. PetersonJul 19, 2017
R-VADave BratJul 20, 2017

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jun 12, 2017
Health Subcommittee
Referred Jun 16, 2017

Actions 3

Everything that happened, newest first.

  1. Jun 16, 2017Referred to the Subcommittee on Health.
  2. Jun 12, 2017Introduced in House
  3. Jun 12, 2017Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H5915Earl L. "Buddy" Carter R-GAJul 17, 2017

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: This bill is enacted pursuant to the power granted to Congress under Article I, Section 8 of the United State Constitution.

The sponsor’s statement, as printed in the Congressional Record, vol. 163, no. 99, June 12, 2017, page H4854.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

ProductTitleKindPublished
R45069Drug Compounding: FDA Authority and Possible Issues for CongressReportJan 5, 2018

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 1959Preserving Patient Access to Compounded Medications Act of 2019Reintroduced BillMar 29, 2019

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act with respect to compounding pharmacies, and for other purposes.
Short Titles as Introduced
Preserving Patient Access to Compounded Medications Act of 2017

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jun 12, 2017Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.